Innospec has secured a £64m deal with Lloyds TSB and other lenders to fund the expansion of its Ellesmere Port-based chemical additives business. [22-Dec-2011]
Angel Biotechnology is raise £1.1m in a share placing to fund the expansion of its fermentation manufacturing capacity and increased staffing costs. [22-Dec-2011]
Avacta Group is to acquire Aptuscan for £1.5m, in order to expand its proprietary reagents and consumables business, and the deal will be funded by a £5.1m share placing. [22-Dec-2011]
Wellcome Trust is planning to invest more than £3bn in medical research over the next five years, up from £2.3bn over the past five years. [22-Dec-2011]
GlaxoSmithKline has sold a portfolio of over-the-counter medicines to US-based Prestige Brands for £426m. [21-Dec-2011]
Sika Liquid Plastics is to submit plans for a £2.5m 12,500 sq ft chemical coatings research laboratory at its site in Preston. [20-Dec-2011]
GlaxoSmithKline has secured a £1.5m Scottish Enterprise grant to expand its research and development facilities in Montrose, with the creation of up to 25 jobs. [20-Dec-2011]
Alliance Pharma has acquired the Quinoderm and Ceanel dermatology brands from Ferndale Pharmaceuticals for £1.5m. [19-Dec-2011]
EMBL-EBI has won £75m of government funding to set up a biological data centre at the Wellcome Trust Genome Campus in Cambridge, with the creation of up to 200 jobs. [12-Dec-2011]
Bostik is to relocate its adhesives warehousing and logistics operation and some of the 350 jobs to a new Stan Robinson Group building in Stafford. [12-Dec-2011]
Tissue Regenix of York has raised £25m in a share placing to fund the commercial development of its tissue replacement technology, with the creation of up to 30 jobs. [12-Dec-2011]
Verona Pharma has raised £3.2m in a share placing to fund the expansion of its London-based biotechnology business. [12-Dec-2011]
Sinclair IS Pharma is to acquire Advanced Bio-Technologies, the supplier of Kelo-cote dermatological products, from HealthEdge Investment Partners for £21m. [12-Dec-2011]
Clariant is seeking a buyer for its 7.6-acre chemicals plant at Church Village near Cardiff, which is due to close next spring with the loss of 95 jobs. [08-Dec-2011]
Jeyes is considering plans to close its cleaning products factory in Mold, Flintshire, with the loss of up to 155 jobs. [08-Dec-2011]
Provexis is to close its sports nutrition research facility in Liverpool and relocate production for its Science in Sport business to a new factory in Nelson. [05-Dec-2011]
Yule Catto has sold Uquifa, the manufacturer of pharmaceutical ingredients with 390 staff in Spain and Mexico, to Vivimed Labs for £35m. [01-Dec-2011]
Standard Soap is to close its soap factory at Ashby in Leicestershire early next year, with the loss of 155 jobs. [28-Nov-2011]
UCB of Belgium is to acquire certain drug discovery and development programmes of Manchester-based Lectus Therapeutics for undisclosed terms. [23-Nov-2011]
Tata Chemicals Europe has appointed Pochin Construction to build a new 18,000 sq ft headquarters at the Brunner Mond complex in Northwich. [17-Nov-2011]
Sinclair IS Pharma has sold its Mysoline prescription-only medicine to Laboratoires SERB of France for £11m. [15-Nov-2011]
Brecon Pharmaceuticals has taken 23,000 sq ft of warehouse space at Treforest Industrial Estate in South Wales. [09-Nov-2011]
SCM Pharma is to invest £5m in the development of 26,000 sq ft of additional pharmaceutical production space at Newburn in Newcastle over the next three years. [08-Nov-2011]
William Sinclair has acquired Yorkshire Horticultural Supplies, the Doncaster-based compost manufacturer, for undisclosed terms. [08-Nov-2011]
BOC is planning to build a £20m acetylene manufacturing plant at its site in Stallingborough next year, with the creation of 40 jobs. [02-Nov-2011]
Redx Pharma has secured RGF funding of £5.9m to support the development of a cancer research centre in Liverpool, with the creation of up to 250 jobs. [01-Nov-2011]
Forza Group is planning to set up a new health supplement products factory in Kent. [01-Nov-2011]
Molecular Profiles is to invest up to £9m in the expansion of its Nottingham-based pharmaceuticals business, including a new 30,000 sq ft research facility and 62 jobs. [31-Oct-2011]
TG Eakin is to invest £6m in the expansion of its skin protection products in Comber, Co Down, by 2013, with the creation of 25 jobs. [31-Oct-2011]
Sirius Minerals has announced a major potash discovery near Whitby in North Yorkshire, and hopes to develop a new mine and create up to 1,000 jobs. [31-Oct-2011]
Speciality Coatings is to shed ten production jobs at its wall coatings business in Darwen. [24-Oct-2011]
Byotrol is to raise £2m in a share placing to fund the expansion of its Warrington-based anti-microbial hygiene business. [24-Oct-2011]
Yule Catto has acquired Quality Polymer, the Malaysian aqueous polymer manufacturer with 30 staff, for £10m. [18-Oct-2011]
Unilever is to acquire Concern Kalina, the Russian skin and haircare company with 1,900 staff, for £342m. [17-Oct-2011]
Thermo Fisher Scientific is considering plans to relocate its Maybridge organic chemicals laboratory and up to 60 staff from Tintagel, Cornwall. [13-Oct-2011]
Axis-Shield, the medical diagnostics firm with sites in Dundee and Uxbridge, is to be acquired by Alere of the US for £235m. [10-Oct-2011]
Leighs Paints is to shed up to 20 of the 276 jobs at its factory in Bolton. [10-Oct-2011]
Life Technologies of the US is considering its site in Renfrewshire as a potential location for a new £25m manufacturing plant. [03-Oct-2011]
The Technology Strategy Board has unveiled plans for a new £30m stem cell therapy research centre in south-east England in 2012, in a project supported by Pfizer, GlaxoSmithKline and AstraZeneca. [03-Oct-2011]
Medpace is to create six jobs at a new clinical research safety office at the University of Stirling. [03-Oct-2011]
Aesica Pharmaceuticals has sold a majority stake in its Northumberland-based drug development business to private equity firm Silverfleet Capital. [03-Oct-2011]
Novartis is to set up a new 64,000 sq ft headquarters for its pharmaceuticals business at Watchmoor Park in Camberley next March. [27-Sep-2011]
Unilever is to close its Alberto Culver hair and beauty products office at Lime Tree Way in Basingstoke, with the loss of 40 jobs and the relocation of the remaining 50 to Leatherhead. [26-Sep-2011]
Akzo Nobel has selected Ashington as the preferred location to build a new £100m paints factory by 2014, with the creation of 140 jobs. [22-Sep-2011]
Horizon Discovery has raised £11m from investors to fund the expansion of its Cambridge-based biotechnology business. [19-Sep-2011]
Procter & Gamble is to close the Basingstoke headquarters of its Wella hair care business in November, and some of the 100 staff will relocate to Bournemouth, London and Weybridge. [15-Sep-2011]
MDY Healthcare has sold its Trust William online healthcare products business to the Optima Consumer Health subsidiary of William Ransom for a nominal sum. [15-Sep-2011]
Crown Paints is to move its distribution centre in Warrington to Hull, and the 70 Warrington-based staff are expected to transfer to its logistics partner CEVA. [14-Sep-2011]
Abcam is to acquire Ascent Scientific, the Bristol-based biochemical reagents supplier with 23 staff, for £10m. [13-Sep-2011]
PolyTherics has raised £2.2m of venture capital to fund the expansion of its London-based biopharmaceutical technologies business. [08-Sep-2011]
AccuNostics has raised £4m to fund the expansion of its Forres-based life sciences business, including the creation of about 30 jobs over the next year. [07-Sep-2011]
Itac has acquired Texas Coating Developments from Allied Textiles for undisclosed terms, and will relocate its waterproof coatings business from Rawtenstall to Radcliffe. [07-Sep-2011]
Multisol, the Nantwich-based chemicals distributor with 170 staff, has been acquired by Brenntag of Germany for an estimated £112m. [05-Sep-2011]
Catalent Pharma Solutions has decided not to rebuild its pharmaceutical packaging facility in Corby following a recent fire, casting doubt on the future of some of the 170 jobs. [31-Aug-2011]
Mission Therapeutics has raised £6m of venture capital to fund the expansion of its Cambridge-based drug discovery business. [30-Aug-2011]
KalVista Pharmaceuticals of Southampton has secured £8m of venture capital investment to fund the development of a new treatment for diabetic macular edema. [24-Aug-2011]
Astellas Pharma has confirmed plans to relocate from Staines to a 90,000 sq ft office at the 2000 Hillswood Drive building in Chertsey later this year. [22-Aug-2011]
European Medicines Agency is planning to set up a 250,000 sq ft office at the 25 Churchill Place development in London E14 in 2015. [15-Aug-2011]
Onyx Scientific, the Sunderland-based drug discovery firm, has been acquired by Ipca Laboratories of India for about £4.6m. [15-Aug-2011]
Lipoxen is to acquire SymbioTec, the German clinical trials firm, for £8.8m. [04-Aug-2011]
BASF is to make a "significant" investment in the expansion of capacity at its polyacrylamide beads plant in Bradford, in order to transfer production from the US. [01-Aug-2011]
E-Therapeutics is to create about ten jobs at a new biotechnology research facility in Oxford by October. [01-Aug-2011]
GlaxoSmithKline has pledged to expand its pharmaceutical manufacturing and research operations in the UK, in response to government tax incentives. [27-Jul-2011]
Tomms Pharmacy is setting up a new 11,700 sq ft facility to supply medication to the care sector at Bartley Point in Hook, Hampshire. [27-Jul-2011]
Immunodiagnostic Systems is planning to expand the workforce at its Boldon-based life sciences business from 100 to 150 by 2013. [27-Jul-2011]
McBride is to close its cleaning products factory in Burnley next March, with the loss of up to 300 jobs, in order to transfer production to Bradford, Manchester and Hull. [25-Jul-2011]
Summit Corporation has raised £1.3m in a share placing to fund the expansion of its Oxford-based drug discovery business. [25-Jul-2011]
Atlas Genetics has raised £17m from Novartis Venture Funds to develop medical diagnostic systems in Bristol and Trowbridge. [25-Jul-2011]
ICON has acquired Firecrest Clinical, the Irish provider of site performance management systems, for undisclosed terms. [18-Jul-2011]
Elemis is setting up a new 50,000 sq ft headquarters for its spa and skincare products business at the Poplar Park development in Bristol. [18-Jul-2011]
Avacta is to relocate its pharmaceutical testing laboratory and 25 jobs from York to its Thorp Arch site in Wetherby in August. [12-Jul-2011]
Merseyside Coatings has been sold out of administration by BDO to a management team, securing 44 jobs at its Widnes-based coatings business. [11-Jul-2011]
Recipharm is to stop sterile manufacturing at its pharmaceuticals site at Bardsley Vale Mills in Ashton, with the loss of 60 of the 285 jobs. [11-Jul-2011]
Teva Pharmaceuticals has won permission to extend its warehouse and clean room at Aston Lane North near Runcorn by 53,000 sq ft. [11-Jul-2011]
Astellas Pharma is reported to be considering the relocation of its pharmaceuticals headquarters from Staines to a 90,000 sq ft building in Chertsey. [11-Jul-2011]
Akzo Nobel is to build a new £100m paints factory in Northumberland by 2014, but existing production facilities that employ 220 staff in Prudhoe and Slough will close. [07-Jul-2011]
Leighs Paints, the Bolton-based industrial paints manufacturer with 260 staff, has been acquired by Sherwin-Williams of the US for undisclosed terms. [07-Jul-2011]
Teva UK is to shed 34 of the 200 jobs at its pharmaceutical packing facility in Eastbourne. [04-Jul-2011]
Equateq is to expand the 31-strong workforce at its Lewis factory by a third, having won a £35m contract to supply omega oil to Irish pharmaceuticals manufacturer Amarin. [04-Jul-2011]
Scancell of Nottingham is to raise £1.7m in a share placing to fund clinical trials for its therapeutic cancer vaccines. [04-Jul-2011]
Trygg Pharma of Norway is to acquire Lundbeck's Seal Sands plant on Teesside for £14m, and will bring the site back into production with the creation of an initial 25 jobs. [29-Jun-2011]
Redx Pharma is seeking government funding to develop a £39m cancer research centre in Liverpool, with the creation of up to 250 jobs over the next five years. [27-Jun-2011]
Pfizer is to retain part of its pharmaceutical sciences facility at Sandwich in Kent, securing about 350 jobs, and hopes to attract other companies to the site. [27-Jun-2011]
Bakhu Pharma has completed the acquisition of the former Phoenix Chemicals site at Newbie out of administration, and plans to increase the workforce to 50 over the next year. [27-Jun-2011]
AstraZeneca is to sell Astra Tech, its Sweden-based dental products business with 2,200 staff, to Dentsply International for about £1.1bn. [22-Jun-2011]
Carr's Milling Industries is to sell Carrs Fertilisers, the fertiliser supplier with sites in Silloth, Invergordon and Montrose, to Origin Enterprises for £19m. [21-Jun-2011]
BWA, the Manchester-based supplier of water treatment chemicals with 85 staff, has been acquired by investment management firm Berwind Corporation for £185m. [21-Jun-2011]
Renovo has confirmed plans to close its drug development facility in Manchester, with the loss of 100 jobs. [20-Jun-2011]
Q Chip has raised a further £3.6m from investors to fund the expansion of its Cardiff-based biotechnology business. [14-Jun-2011]
Crown Paints, the Lancashire-based paints manufacturer with about 1,500 staff, is to be sold by private equity firm Endless to Hempel of Denmark for undisclosed terms. [13-Jun-2011]
Akzo Nobel is creating 40 jobs at its new £6m fire protection coatings laboratory in Gateshead. [08-Jun-2011]
Peri-dent is planning to close its dental products factory in Tweedbank, near Galashiels, with the loss of most of the 132 jobs, in order to transfer production to Malaysia. [07-Jun-2011]
Lumora has raised £1.5m from Catapult Venture Managers and others to fund the expansion of its Cambridgeshire-based molecular diagnostics business. [31-May-2011]
Bridgehaugh Dyeworks is to close its dye factory in Selkirk with the loss of 25 jobs, following a fire. [25-May-2011]
Lab21 is to acquire Myconostica, the Manchester-based developer of molecular diagnostic products, from Amphion Innovations. [24-May-2011]
Abcam has acquired MitoSciences, the US provider of mitochondrial research tools with 24 staff, for £3.7m. [24-May-2011]
EKF Diagnostics is to acquire Stanbio Laboratory, the US medical diagnostic devices firm, for £16m. [23-May-2011]
Shire Pharmaceuticals is to acquire Advanced BioHealing, the US regenerative medicine firm with 400 staff, for £462m. [18-May-2011]
Pfizer is planning to close its pharmaceuticals operation at the University of Aberdeen, with the loss of 24 jobs. [18-May-2011]
Huntsman is to relocate its Teesside-based pigments division and 290 staff to a new site at Wynyard Park, including a 54,000 sq ft office and 31,000 sq ft laboratory. [11-May-2011]
Elan is to sell Elan Drug Technologies, its drug formulation business, to Alkermes of the US for £590m. [10-May-2011]
Syntopix Group is to acquire Leeds Skin Centre for Applied Research, the Wetherby-based testing laboratory, for £0.9m. [09-May-2011]
Manchester Organics has sold a 51% stake in its Runcorn-based chemicals business to Navin Fluorine International of India for £4.3m. [09-May-2011]
Oxford Nanopore Technologies has raised £25m in a share placing to fund improvements to its biotechnology production facilities. [04-May-2011]
Manesty, the Merseyside-based pharmaceutical equipment manufacturer with 110 staff, has been acquired by Bosch of Germany for undisclosed terms. [03-May-2011]
A-Gas has raised £70m from the sale of a stake to private equity firm LDC, in order to fund the expansion of its Bristol-based industrial gases and chemicals business. [28-Apr-2011]
Binding Site, the Birmingham-based biotechnology company, has been acquired by private equity firm Nordic Capital for undisclosed terms. [27-Apr-2011]
RSM Tenon is in negotiations to sell the 154-acre former Phoenix Chemicals site in Annan out of administration to Bakhu Pharma. [18-Apr-2011]
Reckitt Benckiser is planning to close its cleaning products factory in Peterlee by 2014, with the loss of 321 jobs. [18-Apr-2011]
Lotte Chemical UK has secured £6.7m of government funding to build a PET manufacturing plant at its Wilton site on Teesside, with the creation of 55 jobs. [13-Apr-2011]
Chirotech is looking to increase the 40-strong workforce at its newly-expanded 33,000 sq ft biotechnology facility at Cambridge Science Park. [12-Apr-2011]
GlaxoSmithKline is considering sites in Montrose, Irvine and Barnard Castle for the development of a new pharmaceuticals plant, which could create up to 1,000 jobs. [11-Apr-2011]
Astex Therapeutics, the Cambridge-based drug discovery firm, has been acquired by SuperGen of the US for up to £75m. [11-Apr-2011]
Chiltern (Early Phase) is planning to close its drug-testing clinic in Dundee, with the loss of 24 jobs. [11-Apr-2011]
Bayer CropScience is looking to sell its 114-acre chemical production plant on the Sweet Briar Road in Norwich, which has 280 staff. [06-Apr-2011]
Bio-Analytical Technologies of India is to create ten jobs at its new office at Manchester Science Parks over the next 18 months. [06-Apr-2011]
Acacia Pharma has raised £6.2m from investors to fund clinical trials for its Cambridge-based pharmaceuticals business. [04-Apr-2011]
Rhodia is looking to sell its 6.4-acre Wortley Low Mills chemicals plant in Leeds, in order to raise funds for the expansion of its remaining business. [31-Mar-2011]
Phlexglobal, the Amersham-based pharmaceutical support services firm with 200 staff, has undergone a management buy-out backed by Inflexion Private Equity for undisclosed terms. [30-Mar-2011]
Unilever has sold its Sanex soap and shower gel brand to Colgate-Palmolive for £585m, in order to secure approval for the recent acquisition of part of Sara Lee. [24-Mar-2011]
Alliance Pharma has acquired the Ashton & Parsons teething treatment and Anbesol mouth ulcer brands from Reckitt Benckiser for £2.6m. [24-Mar-2011]
Randox Laboratories is to invest £16m in the expansion of its biotechnology facilities in Antrim, with the creation of 242 jobs. [21-Mar-2011]
Novartis is to shed 600 of the 950 jobs at its pharmaceuticals manufacturing and research facility in Horsham, West Sussex. [17-Mar-2011]
Futura Medical has raised £3m in a share placing to fund the expansion of its Guildford-based pharmaceuticals business. [14-Mar-2011]
Instem Life Science Systems has acquired BioWisdom, the Cambridge-based drug discovery firm with 13 staff, for an initial £0.9m. [07-Mar-2011]
Renovo is to shed 100 jobs at its Manchester-based drug discovery business, due to disappointing trials for its anti-scarring product. [07-Mar-2011]
MSD Biologics, the Billingham-based biotechnology firm with 480 staff, is to be acquired by Fujifilm of Japan, as part of a £300m deal that also includes US-based Diosynth RTP. [03-Mar-2011]
Aesica Pharmaceuticals has acquired three manufacturing sites in Germany and Italy from UCB. [03-Mar-2011]
Genzyme, the pharmaceuticals firm with 300 staff in Haverhill, has been acquired by Sanofi-Aventis of France for £12bn. [28-Feb-2011]
ProStrakan, the Galashiels-based pharmaceuticals firm with 300 staff, is to be acquired by Kyowa Hakko Kirin Co of Japan for £292m. [22-Feb-2011]
Trimega is to create ten jobs at its new £1m drug and alcohol testing laboratory in Manchester this year. [21-Feb-2011]
Wells Plastics, the Staffordshire-based additives manufacturer, has undergone a £3.8m management buy-out backed by Key Capital Partners. [21-Feb-2011]
NextPharma Technologies, the Surrey-based provider of services to the pharmaceutical sector, has been acquired by Sun Capital Partners. [21-Feb-2011]
E-Therapeutics has secured an equity investment of £18m from Invesco, in order to fund clinical trials for its drug discovery business. [16-Feb-2011]
Sinclair Pharma and IS Pharma are in merger discussions that would lead to the creation of a pan-European speciality pharmaceuticals group called Sinclair IS Pharma. [15-Feb-2011]
SC Johnson is considering plans to close its cleaning products factory in Frimley, Surrey, with the loss of about 200 jobs. [14-Feb-2011]
Tennants Consolidated has acquired Tessenderlo Fine Chemicals of Leek for £17m. [08-Feb-2011]
CM&D Pharma, the London-based medical gums supplier, has been acquired by Nestle for undisclosed terms. [03-Feb-2011]
Pfizer is to close its research and development site in Sandwich, Kent, with the loss of up to 2,400 jobs over the next two years. [02-Feb-2011]
Solvert is looking to set up a £100m factory to convert organic waste into chemicals on Teesside by 2015, with the creation of up to 80 jobs. [31-Jan-2011]
Oxford BioMedica is to acquire a 16,000 sq ft manufacturing facility in Oxford from RecipharmCobra Biologics for £1.9m, with the creation of up to 40 jobs. [31-Jan-2011]
Angel Biotechnology has raised £1.9m in a share placing to fund the reopening of its manufacturing plant in Newcastle, with the creation of up to ten jobs. [31-Jan-2011]
Aesica is planning to double the size of its R5 Pharmaceuticals factory and laboratory business at BioCity Nottingham, with the creation of up to 30 jobs. [24-Jan-2011]
PRA, the clinical research firm, is said to be in negotiations to set up a 43,000 sq ft office at Green Park in Reading. [24-Jan-2011]
Waters Corporation is planning to relocate its research business and 513 staff from four sites to a new £60m headquarters and laboratory in Wilmslow in 2013, with the creation of 100 new jobs. [20-Jan-2011]
LGC has sold its chemical characterisation division in Runcorn to SGS, with the transfer of eight staff. [17-Jan-2011]
J&H Bunn, the Great Yarmouth-based fertiliser supplier with 150 staff at 12 sites, is to be acquired by Koch Fertilizer for undisclosed terms. [12-Jan-2011]
Ineos has formed a joint venture with PetroChina that will secure the future of 1,400 jobs at its refinery and petrochemicals plant in Grangemouth. [11-Jan-2011]
Soapworks, the Glasgow-based soap manufacturer with 100 staff, has undergone a management buy-out from L'Oreal of France for undisclosed terms. [10-Jan-2011]
Crysalin has secured a £1.5m equity investment to fund the commercial development of its protein structure determination technology at sites in Oxford and London. [05-Jan-2011]
Allergy Therapeutics is planning to shed up to 23 jobs at its speciality pharmaceuticals business in Worthing. [04-Jan-2011]
Sigma Pharmaceuticals has acquired four new warehouse units totalling 40,910 sq ft at the Watford Business Park. [04-Jan-2011]